Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder.

ABSTRACT:

Importance

Retention in addiction treatment is associated with reduced mortality for individuals with opioid use disorder (OUD). Although clinical trials support use of OUD medications among youths (adolescents and young adults), data on timely receipt of buprenorphine hydrochloride, naltrexone hydrochloride, and methadone hydrochloride and its association with retention in care in real-world treatment settings are lacking.

Objectives

To identify the proportion of youths who received treatment for addiction after diagnosis and to determine whether timely receipt of OUD medications is associated with retention in care.

Design, setting, and participants

This retrospective cohort study used enrollment data and complete health insurance claims of 2.4 million youths aged 1

SUBMITTER: Hadland SE 

PROVIDER: S-EPMC6218311 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature